Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung cancer
Pharma
Tagrisso rival loses EU approval after AZ legal challenge
EU regulators revoked Aumseqa’s approval after the EMA ruled that Hansoh’s application illegally referenced AstraZeneca’s Tagrisso.
Angus Liu
Sep 30, 2026 11:13am
Increased deaths shadow Enhertu’s first-line lung cancer data
Sep 13, 2026 7:00pm
Failed Trodelvy first-line NSCLC trial shows better China data
Sep 12, 2026 9:45pm
Akeso, Summit’s ivonescimab hits OS goal in Keytruda head-to-head
Sep 3, 2026 10:29am
Biokin, BMS' bispecific ADC hits goal in China lung cancer trial
Aug 18, 2026 11:18am
GSK’s first lung cancer approval, a new IPO path and more
Jul 24, 2026 9:42am